Search

everythinglearnresearchcommunity

for

Search:↓

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Polyomavirus A2 infection in newborn mice caused hair follicle tumors.

Cepharanthine could be a strong antiviral against COVID-19.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Understanding how our bodies interact with mosquito-borne viruses is crucial because there are few treatments and vaccines.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

A blood pressure drug, diltiazem, may also help treat influenza.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

The study found specific skin and cell changes in patients with monkeypox, helping diagnose and understand the disease.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Honeybees face serious threats from various diseases, but beekeepers use several methods to manage and control them.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

The E2 protein affects gene activity in hair follicles of mice.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.